Vol. 3 No. 3 (2020): Open Journal of Gastroenterology and Hepatology
Research Articles

Pure alphafetoprotein producing neuroendocrine carcinoma of the stomach: A case report

Chen-Wei Chu1, Chien-ho Tsai2, Yu-Huan Huang3, Chun-I Tsai4, Swei-hsiung H Tsung5
1.Department of Medicine, Taipei Veterans General Hospital, Yuanshan branch, Yuanshan, Yilan, Taiwan. 2.Deparment of surgery, National Yang-Ming University Hospital, Yilan.Taiwan. 3.Department of Nursing, National Yang-Ming University Hospital, Yilan, Taiwan 4.Chun-I Tsai Medical Clinic. Yilan, Taiwan. 5.Department of Pathology, St Mary’s Hospital, Loudong, Yilan, Taiwan


  • gastric cancer. Alpha-fetoprotein. Neuroendocrine carcinoma. Chemotherapy. Immunohistochemical stainings. Radiological recurrence.

How to Cite

Chen-Wei Chu1, Chien-ho Tsai2, Yu-Huan Huang3, Chun-I Tsai4, Swei-hsiung H Tsung5. (2020). Pure alphafetoprotein producing neuroendocrine carcinoma of the stomach: A case report. Open Journal of Gastroenterology and Hepatology, 3(3), 41. https://doi.org/10.28933/ojgh-2020-09-1307


Alpha-fetoprotein-producing gastric carcinoma (AFP-GC) is a rare malignant tumor, and has been regarded as a distinct category because of its particularly aggressive biological behavior and poor patient prognosis. In the literature, AFP-GC was never reported in neuroendocrine carcinoma of the stomach. In this article, we described a 60-year old man who sought medical attention because of epigastric pain and poor appetite. His laboratory data were within normal limits except for elevated serum level of alpha-fetoprotein. He was found to have an ulcer on gastroscopic examination which led to the final diagnosis of AFP producing neuroendocrine carcinoma of the stomach. He underwent a radical gastrectomy followed by chemotherapy using leucovorin and 5-fluorouracil.His disease was brought under remission for only six months before radiological recurrence occurred. His recurrent disease was treated with irinotican plus cisplatin without a significant response. His prognosis looked grave. We reported the first case of AFP producing gastric neuroendocrine carcinoma to share our experience.


  1. Bourreille J, Metayer P, Sauger F, Matray F, Fondimare A. Existence of alpha-fetoprotein gastric origin secondary cancer of the liver. Presse Med. 1970; 78:1277-1278.
  2. Li XD, Wu CP, Ji M, Wu J, Lu B, Shi HB, Jiang JT. Characteristic analysis of alpha-fetoprotein producing gastric cancer in China. World J Surg Oncology. 2013;11:246-251
  3. Takahashi Y, Mai O, Ueda H, Sawaguchi K, Ueno M.Clinical pathological study of AFP producing gastric cancer. J Jpn Surg SOC Clin Surg. 1987; 88:696-700.
  4. Kinjo T, Taniguchi H, Kushima R, Sekine S, Oda I, Saka M, Gotoda T, Kinjo F, Fujita J, Shimoda T. Histologic and immunohistochemical analysis of a-fetoprotein-producing cancer of the stomach. Am J Surg Pathol. 2012; 36:56-65.
  5. La Rosa S, Rindi G, Solcia E, Tang LH. Gastric neuroendocrine neoplasm. WHO Classification of Tumor of the Digestive System. Lyon IABC Press: 2019:104-109
  6. Suzuki A, Koide N, Kitazawa M, Mochizuka A, Ota H, Migayawa S. Gastric composite tumor of alpha-fetoprotein producing carcinoma/hepatoid adenocarcinoma and endocrine carcinoma with reference to cellular phenotypes. Pathology Re-search International. 2011; 2012:1-8.
  7. Ishida M, Sekine S, Fukagawa T, Ohashi M, Morita S, Taniguchi H, Katai H, Tsuda H, Kushima. Neuroendocrine carcinoma of the stomach: morphologic and immunohistochemical characteristics and prognosis. Am J Surg Pathol. 2013; 37:949-959.
  8. News. Clinical Investigation. 2011; 1:9-12.
  9. Aizawa M, Nagatuma A, Kitada K, Kuwata T, FujiiS, Kinoshita T, Ochiai. Evaulation of HER2-based biology in 1006 cases of gastric cancer in Japanese population. Gastric Cancer. 2014; 1: 34-42.
  10. Kuo CY, Tsai CI, Tsung SH. Complete Clinical Response of a Patient with Advanced Alpha-fetoprotein Producing Gastric Cancer Treated with Chemotherapy and Trastuzumab. Gastroin-retinal Cancer: Research and Therapy. 2017; 2:1-3.